-
Transplanting Kidneys from HCV-Infected Donors into HCV-Negative Recipients: Longer-Term and Extended Results of the THINKER Trial
-
Treatment and Outcomes of Orthotopic Liver Transplant Patients Secondary to Hepatitis C Virus: A Single Center Experience
-
Treatment of Active Chronic Antibody-Mediated Rejection with Rituximab, IVIG and Plasma Exchange
-
Treatment of BK Viremia: Single-Center Experience
-
Treatment of HCV Infection in Renal Transplant Recipients
-
Treatment of Multi-Drug Resistant Gram Negative Infections after Solid Organ Transplant
-
Treatment of Post Transplant Hepatitis C (HCV) with Direct-Acting Antiviral (DAA) Agents May Improve Liver Function but Does Not Lead to an Increase in Liver Rejection
-
Treatment Outcomes of FSGS Recurrence
-
Treatment Outcomes of Recurrent Primary Focal Segmental Glomerulosclerosis (FSGS) after Kidney Transplantation
-
Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis
- « Previous Page
- 1
- …
- 197
- 198
- 199
- 200
- 201
- …
- 211
- Next Page »